How can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can RWE be used to solve common challenges with treatment comparison? In...
Read More
What is IDAP? As the IDAP pilot opens, we explore how this new pathway offers a fast-track route to patient access for innovative medical technologies.
Calum Jones (Associate Director – Health Economics) shares his experience speaking at the 2024 HTAi Conference. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health Technology Assessment (HTA): From Trials to Economic Evaluations’.
What’s involved in conducting a systematic review? Our evidence experts outline the 7 stages for developing a HTA-ready gold-standard systematic literature review.
We delve into ICER’s influence on drug pricing and access in the US. We also explore the importance of maximising engagement with ICER for favourable pricing and access outcomes.
We're thrilled to announce that Mtech Access will be exhibiting at the ISPOR conference May 5–8 in Atlanta, Georgia, USA! As regular attendees of ISPOR Europe, we're excited to be...
Read More
Hayley Shoel shares her experience of joining Mtech Access’ specialist medical writing team. Explore the different types of projects she’s working on. Discover what you could expect if you joined us at Mtech Access.
Rachel Hibbs (Consultant – Systematic Review) tells us about her career to date and what inspired her to join Mtech Access.
We bring together specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024-25. Jump in, as our experts give their hot-take on each trend, sharing their perspectives on what’s happening in these areas.
Discover 11 common problems that may arise when cost-cutting compromises the quality of your systematic literature review.
